Cite
HARVARD Citation
Aluwini, S. et al. (n.d.). Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial. Lancet oncology. 17 (4), pp. 464-474. [Online].